Synchrony Financial (SYF) Could Be 20% Below Fair Value Following Vetspire Partnership

Synchrony Financial (SYF) drew fresh attention after CareCredit, its healthcare financing arm, agreed to embed payment options directly into Vetspire’s AI veterinary platform, linking consumer credit with real time pet care decisions.

The recent Vetspire deal lands at a tricky moment for the stock, with the share price down 15.27% year to date and 8.11% over the past month. At the same time, Synchrony Financial’s 3-year total shareholder return of about 162% signals long-run momentum that investors will weigh against these newer AI and healthcare driven growth efforts.

Scan other AI driven finance plays by reviewing the hand picked 38 AI small caps that are already wiring credit and payments into real time digital experiences.

Synchrony Financial is wiring credit deeper into everyday pet care just as the share price has pulled back. The company has a strong platform, new AI partnerships, and a record of solid long term returns. Is that combination actually on sale today?

Most Popular Narrative: 19.6% Undervalued

Synchrony Financial closed at $71.72 while the most followed narrative pegs fair value around $89.22, so the gap between market price and modeled worth is doing the heavy lifting in this story.

The company’s expansion in high-growth verticals like health, wellness, and pet financing, where it is resuming growth after recent credit tightening, broadens the consumer base and diversifies revenue streams, contributing to more sustainable earnings growth and risk mitigation over the long run.

See why 34 investors see Synchrony Financial as 20% undervalued.

Result: Fair Value of $89.22 (UNDERVALUED)

Still, the Synchrony Financial story can break if partner concentration with giants like Amazon and Walmart bites, or if fintech competition steadily chips away at card demand.

Find out about the key risks to this Synchrony Financial narrative.

Next Steps

Mixed feelings about Synchrony Financial so far. If you want to move quickly and form your own view, weigh its 4 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Synchrony Financial?

Do not stop with one stock. Use the Simply Wall St Screener to quickly surface fresh opportunities that fit the way you like to invest.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SYF.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]